Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Eptacog alfa (activated)

EU orphan designation number: EU/3/05/333   
Active ingredient: Eptacog alfa (activated)
Indication: Treatment of diffuse alveolar haemorrhage
Sponsor: Pharmaorigin ApS
c/o Serendex Pharmaceuticals A/S, Slotsmarken 17, 2.tv. 2970 Hørsholm, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2005 Orphan Designation EMEA/OD/063/05 (2005)5629 of 14/12/2005
04/04/2007 Change of address of sponsor
21/05/2007 Transfer of orphan designation EMEA/OD/063/05/T/01 (2007)2168 of 14/05/2007
08/04/2008 Change of address of sponsor
24/11/2008 Change of address of sponsor
17/02/2010 Change of address of sponsor
14/02/2015 Change of address of sponsor